PCOS and Obesity: Contraception Challenges
- Meczekalski B, Rasi M, Battipaglia C, Fidecicchi T, Bala G, Szeliga A, Luisi S, Genazzani AD. PCOS and Obesity: Contraception Challenges Open Access Journal of Contraception
Publication Category: Metabolic Health
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
- Feng G, Targher G, Byrne CD, Yilmaz Y, Wai-Sun Wong V, Adithya Lesmana CR, Adams LA, Boursier J, Papatheodoridis G, El-Kassas M, Méndez-Sánchez N, Sookoian S, Castera L, Chan WK, Ye F, Treeprasertsuk S, Cortez-Pinto H, Yu HH, Kim W, Romero-Gómez M, Nakaji Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021 JHEP Rep
Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities
- Bailey CJ, Flatt PR, Conlon JM. Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities The Journal of Peptide Science
The socioeconomic and environmental determinants of metabolic dysfunction-associated steatotic liver disease: 2010 to 2021
- Lorek D, Lupina K, Bisaga W, Malicki D, Stepien W, Kumor L, Janczura J. The socioeconomic and environmental determinants of metabolic dysfunction-associated steatotic liver disease: 2010 to 2021 JHEP Reports
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry
-
Elshorbagy A, Vallejo-Vaz AJ, Barkas F, Lyons ARM, Stevens CAT, Dharmayat KI, Catapano AL, Freiberger T, Hovingh GK, Mata P, Raal FJ, Santos RD, Soran H, Watts GF, Abifadel M, Aguilar-Salinas CA, Alhabib KF, Alkhnifsawi M, Almahmeed W, Alnouri F, Alonso R
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry European Heart Journal
A Comprehensive Review of the Role of GLP-1 Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure
-
Gul U, Aung T, Martin M, Farrukh DN, Shah PC, Lovely ZS, Marroquín León E, Alansaari M, Maini S, Fariduddin MM, Ullah A, Nazir Z.
A Comprehensive Review of the Role of GLP-1 Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure Cureus
Mechanisms in endocrinology: hypogonadism and metabolic health in men-novel insights into pathophysiology
-
Miller C, Madden-Doyle L, Jayasena C, McIlroy M, Sherlock M, O'Reilly MW.
Mechanisms in endocrinology: hypogonadism and metabolic health in men-novel insights into pathophysiology Eur J Endocrinol
GLP-1 therapy increases visceral adipose tissue metabolic activity: lessons from a randomized controlled trial in obstructive sleep apnea
-
O'Donnell C, Ryan O, Hogan AE, Killick D, Crilly S, Dodd JD, Murphy DJ, Ryan S, O'Shea D.
GLP-1 therapy increases visceral adipose tissue metabolic activity: lessons from a randomized controlled trial in obstructive sleep apnea Obesity (Silver Spring)
Metabolic/Bariatric Surgery is Safe and Effective in People with Obesity, Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Cohen RV, Azevedo MA, Le Roux CW, Caldeon LP, Luque A, Fayad DA, Petry TBZ. Metabolic/Bariatric Surgery is Safe and Effective in People with Obesity, Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Obes Surg
Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement
-
Haddad A, Suter M, Greve JW, Shikora S, Prager G, Dayyeh BA, Galvao M, Grothe K, Herrera M, Kow L, Le Roux C, O'Kane M, Parmar C, Quadros LG, Ramos A, Vidal J, Cohen RV.
Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement Obes Surg